Chloroquine sensitises hypoxic colorectal cancer cells to ROS-mediated cell death via structural disruption of pyruvate dehydrogenase kinase 1

Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still not known. The present study investigated the effect of CQ on colorectal cancer cells to elucidate the underlying molecular mechanisms. We r...

Full description

Saved in:
Bibliographic Details
Published in:Free radical biology & medicine Vol. 227; pp. 656 - 666
Main Authors: Mir, Irfan Ahmad, Mir, Hilal Ahmad, Mehraj, Umar, Bhat, Mohd Younus, Mir, Manzoor Ahmad, Dar, Tanveer Ali, Hussain, Mahboob-Ul
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01.02.2025
Subjects:
ISSN:0891-5849, 1873-4596, 1873-4596
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still not known. The present study investigated the effect of CQ on colorectal cancer cells to elucidate the underlying molecular mechanisms. We report for the first time that CQ suppresses hypoxia-induced growth and survival of HCT-116 cells by reducing glycolytic capacity and NAD+ production through inhibition of PDK1. Furthermore, in silico and in vitro studies revealed that CQ induces structural alteration in the PDK1 protein, leading to its destabilization and promotes its enhanced degradation by proteases. This degradation is in turn inhibited by the MG-132 protease inhibitor. Moreover, CQ-induced suppression of PDK1 results in mitochondrial damage through excessive production of ROS, as reflected by the reduction in mitochondrial membrane potential, which in turn triggers apoptosis through PARP cleavage and Caspase activation. These findings advocate CQ as a promising repurposable chemotherapeutic for colorectal cancer and a novel inhibitor of PDK1. In absence of Chloroquine-Active PDK1 inhibits activity of pyruvate dehydrogenase complex (PDHC) promoting Warburg effect, which inhibits ROS generation and stimulates cell survival and growth.In presence of Chloroquine –CQ-induced destabilization of PDK1 promotes its degradation, resulting in increased mitochondrial oxidative phosphorylation (OXPHOs) thereby increasing ROS generation and cell death. [Display omitted] •CQ suppresses proliferation of hypoxic HCT-116 cells through the inhibition of anaerobic glycolysis.•This effect of CQ is facilitated by its targeting of PDK1, a kinase crucial for glycolytic reprogramming during hypoxa.•CQ directly binds to PDK1, affecting its overall conformation, stability, and bioavailability.•CQ-mediated loss of PDK1 triggers ROS-dependent apoptosis in HCT-116 cells by reducing mitochondrial activity.
AbstractList Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still not known. The present study investigated the effect of CQ on colorectal cancer cells to elucidate the underlying molecular mechanisms. We report for the first time that CQ suppresses hypoxia-induced growth and survival of HCT-116 cells by reducing glycolytic capacity and NAD+ production through inhibition of PDK1. Furthermore, in silico and in vitro studies revealed that CQ induces structural alteration in the PDK1 protein, leading to its destabilization and promotes its enhanced degradation by proteases. This degradation is in turn inhibited by the MG-132 protease inhibitor. Moreover, CQ-induced suppression of PDK1 results in mitochondrial damage through excessive production of ROS, as reflected by the reduction in mitochondrial membrane potential, which in turn triggers apoptosis through PARP cleavage and Caspase activation. These findings advocate CQ as a promising repurposable chemotherapeutic for colorectal cancer and a novel inhibitor of PDK1. In absence of Chloroquine-Active PDK1 inhibits activity of pyruvate dehydrogenase complex (PDHC) promoting Warburg effect, which inhibits ROS generation and stimulates cell survival and growth.In presence of Chloroquine –CQ-induced destabilization of PDK1 promotes its degradation, resulting in increased mitochondrial oxidative phosphorylation (OXPHOs) thereby increasing ROS generation and cell death. [Display omitted] •CQ suppresses proliferation of hypoxic HCT-116 cells through the inhibition of anaerobic glycolysis.•This effect of CQ is facilitated by its targeting of PDK1, a kinase crucial for glycolytic reprogramming during hypoxa.•CQ directly binds to PDK1, affecting its overall conformation, stability, and bioavailability.•CQ-mediated loss of PDK1 triggers ROS-dependent apoptosis in HCT-116 cells by reducing mitochondrial activity.
Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still not known. The present study investigated the effect of CQ on colorectal cancer cells to elucidate the underlying molecular mechanisms. We report for the first time that CQ suppresses hypoxia-induced growth and survival of HCT-116 cells by reducing glycolytic capacity and NAD+ production through inhibition of PDK1. Furthermore, in silico and in vitro studies revealed that CQ induces structural alteration in the PDK1 protein, leading to its destabilization and promotes its enhanced degradation by proteases. This degradation is in turn inhibited by the MG-132 protease inhibitor. Moreover, CQ-induced suppression of PDK1 results in mitochondrial damage through excessive production of ROS, as reflected by the reduction in mitochondrial membrane potential, which in turn triggers apoptosis through PARP cleavage and Caspase activation. These findings advocate CQ as a promising repurposable chemotherapeutic for colorectal cancer and a novel inhibitor of PDK1.Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still not known. The present study investigated the effect of CQ on colorectal cancer cells to elucidate the underlying molecular mechanisms. We report for the first time that CQ suppresses hypoxia-induced growth and survival of HCT-116 cells by reducing glycolytic capacity and NAD+ production through inhibition of PDK1. Furthermore, in silico and in vitro studies revealed that CQ induces structural alteration in the PDK1 protein, leading to its destabilization and promotes its enhanced degradation by proteases. This degradation is in turn inhibited by the MG-132 protease inhibitor. Moreover, CQ-induced suppression of PDK1 results in mitochondrial damage through excessive production of ROS, as reflected by the reduction in mitochondrial membrane potential, which in turn triggers apoptosis through PARP cleavage and Caspase activation. These findings advocate CQ as a promising repurposable chemotherapeutic for colorectal cancer and a novel inhibitor of PDK1.
Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still not known. The present study investigated the effect of CQ on colorectal cancer cells to elucidate the underlying molecular mechanisms. We report for the first time that CQ suppresses hypoxia-induced growth and survival of HCT-116 cells by reducing glycolytic capacity and NAD production through inhibition of PDK1. Furthermore, in silico and in vitro studies revealed that CQ induces structural alteration in the PDK1 protein, leading to its destabilization and promotes its enhanced degradation by proteases. This degradation is in turn inhibited by the MG-132 protease inhibitor. Moreover, CQ-induced suppression of PDK1 results in mitochondrial damage through excessive production of ROS, as reflected by the reduction in mitochondrial membrane potential, which in turn triggers apoptosis through PARP cleavage and Caspase activation. These findings advocate CQ as a promising repurposable chemotherapeutic for colorectal cancer and a novel inhibitor of PDK1.
Author Mir, Manzoor Ahmad
Mir, Irfan Ahmad
Hussain, Mahboob-Ul
Bhat, Mohd Younus
Mehraj, Umar
Dar, Tanveer Ali
Mir, Hilal Ahmad
Author_xml – sequence: 1
  givenname: Irfan Ahmad
  orcidid: 0009-0007-7477-5713
  surname: Mir
  fullname: Mir, Irfan Ahmad
  organization: Department of Biotechnology, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India
– sequence: 2
  givenname: Hilal Ahmad
  surname: Mir
  fullname: Mir, Hilal Ahmad
  organization: Department of Biotechnology, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India
– sequence: 3
  givenname: Umar
  surname: Mehraj
  fullname: Mehraj, Umar
  organization: Department of Pathology, Duke University, Durham, NC 27710, USA
– sequence: 4
  givenname: Mohd Younus
  surname: Bhat
  fullname: Bhat, Mohd Younus
  organization: Department of Clinical Biochemistry, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India
– sequence: 5
  givenname: Manzoor Ahmad
  surname: Mir
  fullname: Mir, Manzoor Ahmad
  organization: Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, 190006, J&K, India
– sequence: 6
  givenname: Tanveer Ali
  surname: Dar
  fullname: Dar, Tanveer Ali
  organization: Department of Clinical Biochemistry, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India
– sequence: 7
  givenname: Mahboob-Ul
  orcidid: 0000-0002-1335-1489
  surname: Hussain
  fullname: Hussain, Mahboob-Ul
  email: Mahboob@uok.edu.in
  organization: Department of Biotechnology, School of Biological Sciences, University of Kashmir, Srinagar, 190006, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39657842$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1q3DAUhUVJaSZpX6EIuunGriRLtkxXZUh_IBBo0rXQSFcdTT2WK8lD5iX6zJUzaSG7rC5cfeeKc84FOhvDCAi9o6SmhLYfdrWLAFHbjQ97sDUjjNeU1YS1L9CKyq6puOjbM7QisqeVkLw_Rxcp7QghXDTyFTpv-lZ0krMV-rPeDiGG37MfAScYk88-QcLb4xTuvcEmlGcwWQ_Y6NFAxAaGIeEc8Peb26r873UG-7DFFnTe4oPXOOU4mzzHIrM-xXnKPow4ODwd43woisJujzaGnzDqBPiXfxj0NXrp9JDgzeO8RD8-X92tv1bXN1--rT9dV6ZhIldOUCI63ZDGONsSJzvbd1QbKTaidRbA8Va6hksruWOCU6BUS-AgCdHO6OYSvT_dnRbvkLLa-7R40COEOamG8rZltMRU0LeP6LwpdtUU_V7Ho_qXYQE-ngATQ0oR3H-EErU0pnbqSWNqaUxRpkpjRX11UkOxe_AQVTIeStLWL7krG_yz7vwFBLOqDQ
Cites_doi 10.1038/nrc2981
10.1080/07357900802427927
10.1007/s10565-016-9319-z
10.1063/1.467468
10.1016/j.cell.2011.02.013
10.1371/journal.pone.0179672
10.1172/JCI40283
10.1016/S1535-6108(03)00085-0
10.1097/CAD.0b013e32832f4e50
10.1172/JCI40027
10.1097/DCR.0b013e31825afc4e
10.1021/acs.jafc.1c04140
10.1093/jnci/82.1.4
10.1126/science.123.3191.309
10.1016/j.semradonc.2008.12.002
10.15252/emmm.202012476
10.1159/000185488
10.1074/jbc.M300463200
10.1021/acsomega.6b00356
10.1186/s12883-016-0700-6
10.3389/fonc.2021.658151
10.3322/caac.21708
10.1186/1471-2407-10-370
10.1016/j.ejphar.2009.06.063
10.3389/fonc.2020.01138
10.1126/science.1160809
10.3727/105221616X693855
10.1016/j.biocel.2010.08.009
10.1007/s10549-014-3128-y
10.1016/j.ccr.2006.10.020
10.1016/j.bmc.2005.12.035
10.1016/j.canlet.2010.01.006
10.3322/caac.21660
10.1016/j.bmc.2008.07.076
10.3389/fcell.2019.00004
10.3389/or.2023.10576
10.1128/MCB.24.7.2875-2889.2004
10.4161/cc.8.17.9544
10.2147/HP.S93413
10.1063/1.445869
10.1038/s41598-017-12513-1
10.1016/j.ccr.2014.06.025
10.1038/srep17397
10.18632/oncotarget.6366
ContentType Journal Article
Copyright 2024 Elsevier Inc.
Copyright © 2024 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2024 Elsevier Inc.
– notice: Copyright © 2024 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.freeradbiomed.2024.12.026
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1873-4596
EndPage 666
ExternalDocumentID 39657842
10_1016_j_freeradbiomed_2024_12_026
S0891584924011304
Genre Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLJU
ABMAC
ABMZM
ABUDA
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AFJKZ
AFTJW
AFXIZ
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
C45
CS3
DU5
EBS
EFJIC
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
LX3
LZ2
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OVD
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
TEORI
~G-
.GJ
.HR
29H
53G
9DU
AAQXK
AAYWO
AAYXX
ABWVN
ABXDB
ACIEU
ACLOT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEUPX
AFPUW
AGHFR
AGQPQ
AGRDE
AHHHB
AIGII
AIIUN
AKBMS
AKYEP
APXCP
ASPBG
AVWKF
AZFZN
CITATION
EFKBS
EFLBG
EJD
FEDTE
FGOYB
G-2
HEA
HLW
HMK
HMO
HVGLF
HX~
HZ~
R2-
SBG
WUQ
XPP
ZGI
~HD
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c325t-f51057a303cfd60f87d971ac85b56fdeef468f348d84f2541e11a8e4e800afca3
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001410191800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0891-5849
1873-4596
IngestDate Sun Sep 28 11:09:53 EDT 2025
Mon Jul 21 06:04:21 EDT 2025
Sat Nov 29 02:30:05 EST 2025
Sun Apr 06 06:54:24 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords MMP
And apoptosis
CQ-Repositioning
Colorectal cancer
ROS
Glycolysis
Hypoxia
PDK1
CQ-Binding
Language English
License Copyright © 2024 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c325t-f51057a303cfd60f87d971ac85b56fdeef468f348d84f2541e11a8e4e800afca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0009-0007-7477-5713
0000-0002-1335-1489
PMID 39657842
PQID 3146621965
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_3146621965
pubmed_primary_39657842
crossref_primary_10_1016_j_freeradbiomed_2024_12_026
elsevier_sciencedirect_doi_10_1016_j_freeradbiomed_2024_12_026
PublicationCentury 2000
PublicationDate 2025-02-01
PublicationDateYYYYMMDD 2025-02-01
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Free radical biology & medicine
PublicationTitleAlternate Free Radic Biol Med
PublicationYear 2025
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Maes (bib27) 2016; 3
Haugrud (bib47) 2014; 147
Muz (bib13) 2015; 3
Fan (bib20) 2006; 14
Bonnet (bib46) 2007; 11
Warburg (bib18) 1956; 123
Lee, Peterson (bib37) 2016; 1
Rouschop (bib9) 2010; 120
Ye (bib24) 2016; 16
Cairns, Harris, Mak (bib15) 2011; 11
Sasaki (bib29) 2010; 10
Folkman (bib5) 1990; 82
Al Tameemi (bib14) 2019; 7
Ishii (bib36) 2017; 7
Erler (bib8) 2004; 24
Pennacchietti (bib10) 2003; 3
Reyes (bib32) 2017; 17
Eloranta (bib41) 2020; 10
Shih (bib7) 2021; 11
Qin (bib43) 2016; 7
Pathy (bib4) 2012; 55
Maes (bib26) 2014; 26
Siegel (bib2) 2022; 72
Zheng (bib23) 2009; 27
Rahim, Strobl (bib21) 2009; 20
Bezawork-Geleta (bib42) 2015; 5
Zhang (bib45) 2017; 12
Kirito, Hu, Komatsu (bib44) 2009; 8
Sung (bib1) 2021; 71
Vaupel, Kallinowski, Okunieff (bib6) 1989; 49
Kioi (bib12) 2010; 120
Hill, Marie-Egyptienne, Hedley (bib11) 2009; 19
Jiang (bib22) 2008; 22
Martyna (bib34) 1994; 101
Pardamean (bib3) 2023; 17
Jorgensen, C, Madura (bib33) 1983; 79
Pan (bib28) 2010; 293
Keta (bib25) 2016; 32
Hanahan, Weinberg (bib16) 2011; 144
Vander Heiden, Cantley, Thompson (bib17) 2009; 324
Solomon, Lee (bib30) 2009; 625
Yuan (bib35) 2003; 278
Yao (bib38) 2021; 69
Park (bib40) 2019; 9
Weljie, Jirik (bib19) 2011; 43
Nirk, Reggiori, Mauthe (bib39) 2020; 12
Hu (bib31) 2008; 16
Hanahan (10.1016/j.freeradbiomed.2024.12.026_bib16) 2011; 144
Keta (10.1016/j.freeradbiomed.2024.12.026_bib25) 2016; 32
Pennacchietti (10.1016/j.freeradbiomed.2024.12.026_bib10) 2003; 3
Folkman (10.1016/j.freeradbiomed.2024.12.026_bib5) 1990; 82
Vaupel (10.1016/j.freeradbiomed.2024.12.026_bib6) 1989; 49
Erler (10.1016/j.freeradbiomed.2024.12.026_bib8) 2004; 24
Pathy (10.1016/j.freeradbiomed.2024.12.026_bib4) 2012; 55
Siegel (10.1016/j.freeradbiomed.2024.12.026_bib2) 2022; 72
Lee (10.1016/j.freeradbiomed.2024.12.026_bib37) 2016; 1
Hill (10.1016/j.freeradbiomed.2024.12.026_bib11) 2009; 19
Shih (10.1016/j.freeradbiomed.2024.12.026_bib7) 2021; 11
Fan (10.1016/j.freeradbiomed.2024.12.026_bib20) 2006; 14
Jorgensen (10.1016/j.freeradbiomed.2024.12.026_bib33) 1983; 79
Park (10.1016/j.freeradbiomed.2024.12.026_bib40) 2019; 9
Maes (10.1016/j.freeradbiomed.2024.12.026_bib26) 2014; 26
Nirk (10.1016/j.freeradbiomed.2024.12.026_bib39) 2020; 12
Eloranta (10.1016/j.freeradbiomed.2024.12.026_bib41) 2020; 10
Rahim (10.1016/j.freeradbiomed.2024.12.026_bib21) 2009; 20
Yuan (10.1016/j.freeradbiomed.2024.12.026_bib35) 2003; 278
Sasaki (10.1016/j.freeradbiomed.2024.12.026_bib29) 2010; 10
Vander Heiden (10.1016/j.freeradbiomed.2024.12.026_bib17) 2009; 324
Zhang (10.1016/j.freeradbiomed.2024.12.026_bib45) 2017; 12
Bonnet (10.1016/j.freeradbiomed.2024.12.026_bib46) 2007; 11
Weljie (10.1016/j.freeradbiomed.2024.12.026_bib19) 2011; 43
Hu (10.1016/j.freeradbiomed.2024.12.026_bib31) 2008; 16
Solomon (10.1016/j.freeradbiomed.2024.12.026_bib30) 2009; 625
Qin (10.1016/j.freeradbiomed.2024.12.026_bib43) 2016; 7
Yao (10.1016/j.freeradbiomed.2024.12.026_bib38) 2021; 69
Pan (10.1016/j.freeradbiomed.2024.12.026_bib28) 2010; 293
Bezawork-Geleta (10.1016/j.freeradbiomed.2024.12.026_bib42) 2015; 5
Haugrud (10.1016/j.freeradbiomed.2024.12.026_bib47) 2014; 147
Ishii (10.1016/j.freeradbiomed.2024.12.026_bib36) 2017; 7
Kirito (10.1016/j.freeradbiomed.2024.12.026_bib44) 2009; 8
Pardamean (10.1016/j.freeradbiomed.2024.12.026_bib3) 2023; 17
Reyes (10.1016/j.freeradbiomed.2024.12.026_bib32) 2017; 17
Rouschop (10.1016/j.freeradbiomed.2024.12.026_bib9) 2010; 120
Al Tameemi (10.1016/j.freeradbiomed.2024.12.026_bib14) 2019; 7
Muz (10.1016/j.freeradbiomed.2024.12.026_bib13) 2015; 3
Martyna (10.1016/j.freeradbiomed.2024.12.026_bib34) 1994; 101
Zheng (10.1016/j.freeradbiomed.2024.12.026_bib23) 2009; 27
Ye (10.1016/j.freeradbiomed.2024.12.026_bib24) 2016; 16
Maes (10.1016/j.freeradbiomed.2024.12.026_bib27) 2016; 3
Warburg (10.1016/j.freeradbiomed.2024.12.026_bib18) 1956; 123
Sung (10.1016/j.freeradbiomed.2024.12.026_bib1) 2021; 71
Kioi (10.1016/j.freeradbiomed.2024.12.026_bib12) 2010; 120
Cairns (10.1016/j.freeradbiomed.2024.12.026_bib15) 2011; 11
Jiang (10.1016/j.freeradbiomed.2024.12.026_bib22) 2008; 22
References_xml – volume: 55
  start-page: 900
  year: 2012
  end-page: 906
  ident: bib4
  article-title: The incidence and survival rates of colorectal cancer in India remain low compared with rising rates in East Asia
  publication-title: Dis. Colon Rectum
– volume: 11
  year: 2021
  ident: bib7
  article-title: Hypoxia-induced MALAT1 promotes the proliferation and migration of breast cancer cells by sponging MiR-3064-5p
  publication-title: Front. Oncol.
– volume: 72
  start-page: 7
  year: 2022
  end-page: 33
  ident: bib2
  article-title: Cancer statistics, 2022
  publication-title: CA Cancer J. Clin.
– volume: 17
  year: 2023
  ident: bib3
  article-title: Changing colorectal cancer trends in asians: epidemiology and risk factors
  publication-title: Oncol. Rev.
– volume: 625
  start-page: 220
  year: 2009
  end-page: 233
  ident: bib30
  article-title: Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies
  publication-title: Eur. J. Pharmacol.
– volume: 123
  start-page: 309
  year: 1956
  end-page: 314
  ident: bib18
  article-title: On the origin of cancer cells
  publication-title: Science
– volume: 7
  year: 2017
  ident: bib36
  article-title: CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
  publication-title: Sci. Rep.
– volume: 43
  start-page: 981
  year: 2011
  end-page: 989
  ident: bib19
  article-title: Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect
  publication-title: Int. J. Biochem. Cell Biol.
– volume: 10
  start-page: 1138
  year: 2020
  ident: bib41
  article-title: Chloroquine triggers cell death and inhibits PARPs in cell models of aggressive hepatoblastoma
  publication-title: Front. Oncol.
– volume: 24
  start-page: 2875
  year: 2004
  end-page: 2889
  ident: bib8
  article-title: Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance
  publication-title: Mol. Cell Biol.
– volume: 9
  year: 2019
  ident: bib40
  article-title: Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
  publication-title: Sci. Rep.
– volume: 49
  start-page: 6449
  year: 1989
  end-page: 6465
  ident: bib6
  article-title: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review
  publication-title: Cancer Res.
– volume: 32
  start-page: 83
  year: 2016
  end-page: 101
  ident: bib25
  article-title: The impact of autophagy on cell death modalities in CRL-5876 lung adenocarcinoma cells after their exposure to gamma-rays and/or erlotinib
  publication-title: Cell Biol. Toxicol.
– volume: 79
  year: 1983
  ident: bib33
  article-title: Comparison of simple potential functions for simulating liquid water
  publication-title: J. Chem. Phys.
– volume: 5
  year: 2015
  ident: bib42
  article-title: LON is the master protease that protects against protein aggregation in human mitochondria through direct degradation of misfolded proteins
  publication-title: Sci. Rep.
– volume: 71
  start-page: 209
  year: 2021
  end-page: 249
  ident: bib1
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J. Clin.
– volume: 293
  start-page: 167
  year: 2010
  end-page: 174
  ident: bib28
  article-title: The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells
  publication-title: Cancer Lett.
– volume: 22
  start-page: 431
  year: 2008
  end-page: 440
  ident: bib22
  article-title: Cell growth inhibition, G2/M cell cycle arrest, and apoptosis induced by chloroquine in human breast cancer cell line Bcap-37
  publication-title: Cell. Physiol. Biochem.
– volume: 8
  start-page: 2844
  year: 2009
  end-page: 2849
  ident: bib44
  article-title: HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1
  publication-title: Cell Cycle
– volume: 3
  start-page: 83
  year: 2015
  end-page: 92
  ident: bib13
  article-title: The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
  publication-title: Hypoxia
– volume: 12
  year: 2020
  ident: bib39
  article-title: Hydroxychloroquine in rheumatic autoimmune disorders and beyond
  publication-title: EMBO Mol. Med.
– volume: 27
  start-page: 286
  year: 2009
  end-page: 292
  ident: bib23
  article-title: Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis
  publication-title: Cancer Invest.
– volume: 120
  start-page: 127
  year: 2010
  end-page: 141
  ident: bib9
  article-title: The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
  publication-title: J. Clin. Invest.
– volume: 16
  start-page: 178
  year: 2016
  ident: bib24
  article-title: Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis
  publication-title: BMC Neurol.
– volume: 3
  year: 2016
  ident: bib27
  article-title: Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature
  publication-title: Mol. Cell Oncol.
– volume: 101
  year: 1994
  ident: bib34
  article-title: Constant pressure molecular dynamics algorithms
  publication-title: J. Chem. Phys.
– volume: 26
  start-page: 190
  year: 2014
  end-page: 206
  ident: bib26
  article-title: Tumor vessel normalization by chloroquine independent of autophagy
  publication-title: Cancer Cell
– volume: 17
  start-page: 129
  year: 2017
  end-page: 140
  ident: bib32
  article-title: Sorafenib and 2-deoxyglucose synergistically inhibit proliferation of both sorafenib-sensitive and -resistant HCC cells by inhibiting ATP production
  publication-title: Gene Expr.
– volume: 324
  start-page: 1029
  year: 2009
  end-page: 1033
  ident: bib17
  article-title: Understanding the Warburg effect: the metabolic requirements of cell proliferation
  publication-title: Science
– volume: 11
  start-page: 37
  year: 2007
  end-page: 51
  ident: bib46
  article-title: A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
  publication-title: Cancer Cell
– volume: 69
  start-page: 10669
  year: 2021
  end-page: 10677
  ident: bib38
  article-title: Binding of chloroquine to whey protein relieves its cytotoxicity while enhancing its uptake by cells
  publication-title: J. Agric. Food Chem.
– volume: 82
  start-page: 4
  year: 1990
  end-page: 6
  ident: bib5
  article-title: What is the evidence that tumors are angiogenesis dependent?
  publication-title: J. Natl. Cancer Inst.
– volume: 11
  start-page: 85
  year: 2011
  end-page: 95
  ident: bib15
  article-title: Regulation of cancer cell metabolism
  publication-title: Nat. Rev. Cancer
– volume: 14
  start-page: 3218
  year: 2006
  end-page: 3222
  ident: bib20
  article-title: Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells
  publication-title: Bioorg. Med. Chem.
– volume: 10
  start-page: 370
  year: 2010
  ident: bib29
  article-title: Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
  publication-title: BMC Cancer
– volume: 1
  start-page: 1266
  year: 2016
  end-page: 1276
  ident: bib37
  article-title: Quantification of small molecule-protein interactions using FRET between tryptophan and the pacific blue fluorophore
  publication-title: ACS Omega
– volume: 12
  year: 2017
  ident: bib45
  article-title: Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells
  publication-title: PLoS One
– volume: 16
  start-page: 7888
  year: 2008
  end-page: 7893
  ident: bib31
  article-title: The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine
  publication-title: Bioorg. Med. Chem.
– volume: 19
  start-page: 106
  year: 2009
  end-page: 111
  ident: bib11
  article-title: Cancer stem cells, hypoxia and metastasis
  publication-title: Semin. Radiat. Oncol.
– volume: 278
  start-page: 15911
  year: 2003
  end-page: 15916
  ident: bib35
  article-title: Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha
  publication-title: J. Biol. Chem.
– volume: 120
  start-page: 694
  year: 2010
  end-page: 705
  ident: bib12
  article-title: Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
  publication-title: J. Clin. Invest.
– volume: 144
  start-page: 646
  year: 2011
  end-page: 674
  ident: bib16
  article-title: Hallmarks of cancer: the next generation
  publication-title: Cell
– volume: 7
  start-page: 1395
  year: 2016
  end-page: 1407
  ident: bib43
  article-title: Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
  publication-title: Oncotarget
– volume: 3
  start-page: 347
  year: 2003
  end-page: 361
  ident: bib10
  article-title: Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
  publication-title: Cancer Cell
– volume: 147
  start-page: 539
  year: 2014
  end-page: 550
  ident: bib47
  article-title: Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells
  publication-title: Breast Cancer Res. Treat.
– volume: 7
  start-page: 4
  year: 2019
  ident: bib14
  article-title: Hypoxia-modified cancer cell metabolism
  publication-title: Front. Cell Dev. Biol.
– volume: 20
  start-page: 736
  year: 2009
  end-page: 745
  ident: bib21
  article-title: Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells
  publication-title: Anti Cancer Drugs
– volume: 11
  start-page: 85
  issue: 2
  year: 2011
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib15
  article-title: Regulation of cancer cell metabolism
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2981
– volume: 27
  start-page: 286
  issue: 3
  year: 2009
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib23
  article-title: Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis
  publication-title: Cancer Invest.
  doi: 10.1080/07357900802427927
– volume: 32
  start-page: 83
  issue: 2
  year: 2016
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib25
  article-title: The impact of autophagy on cell death modalities in CRL-5876 lung adenocarcinoma cells after their exposure to gamma-rays and/or erlotinib
  publication-title: Cell Biol. Toxicol.
  doi: 10.1007/s10565-016-9319-z
– volume: 101
  issue: 5
  year: 1994
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib34
  article-title: Constant pressure molecular dynamics algorithms
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.467468
– volume: 144
  start-page: 646
  issue: 5
  year: 2011
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib16
  article-title: Hallmarks of cancer: the next generation
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
– volume: 12
  issue: 6
  year: 2017
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib45
  article-title: Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0179672
– volume: 120
  start-page: 694
  issue: 3
  year: 2010
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib12
  article-title: Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI40283
– volume: 3
  start-page: 347
  issue: 4
  year: 2003
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib10
  article-title: Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00085-0
– volume: 20
  start-page: 736
  issue: 8
  year: 2009
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib21
  article-title: Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells
  publication-title: Anti Cancer Drugs
  doi: 10.1097/CAD.0b013e32832f4e50
– volume: 120
  start-page: 127
  issue: 1
  year: 2010
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib9
  article-title: The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI40027
– volume: 55
  start-page: 900
  issue: 8
  year: 2012
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib4
  article-title: The incidence and survival rates of colorectal cancer in India remain low compared with rising rates in East Asia
  publication-title: Dis. Colon Rectum
  doi: 10.1097/DCR.0b013e31825afc4e
– volume: 69
  start-page: 10669
  issue: 36
  year: 2021
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib38
  article-title: Binding of chloroquine to whey protein relieves its cytotoxicity while enhancing its uptake by cells
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.1c04140
– volume: 82
  start-page: 4
  issue: 1
  year: 1990
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib5
  article-title: What is the evidence that tumors are angiogenesis dependent?
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/82.1.4
– volume: 123
  start-page: 309
  issue: 3191
  year: 1956
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib18
  article-title: On the origin of cancer cells
  publication-title: Science
  doi: 10.1126/science.123.3191.309
– volume: 19
  start-page: 106
  issue: 2
  year: 2009
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib11
  article-title: Cancer stem cells, hypoxia and metastasis
  publication-title: Semin. Radiat. Oncol.
  doi: 10.1016/j.semradonc.2008.12.002
– volume: 12
  issue: 8
  year: 2020
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib39
  article-title: Hydroxychloroquine in rheumatic autoimmune disorders and beyond
  publication-title: EMBO Mol. Med.
  doi: 10.15252/emmm.202012476
– volume: 22
  start-page: 431
  issue: 5–6
  year: 2008
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib22
  article-title: Cell growth inhibition, G2/M cell cycle arrest, and apoptosis induced by chloroquine in human breast cancer cell line Bcap-37
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000185488
– volume: 278
  start-page: 15911
  issue: 18
  year: 2003
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib35
  article-title: Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M300463200
– volume: 1
  start-page: 1266
  issue: 6
  year: 2016
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib37
  article-title: Quantification of small molecule-protein interactions using FRET between tryptophan and the pacific blue fluorophore
  publication-title: ACS Omega
  doi: 10.1021/acsomega.6b00356
– volume: 16
  start-page: 178
  issue: 1
  year: 2016
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib24
  article-title: Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis
  publication-title: BMC Neurol.
  doi: 10.1186/s12883-016-0700-6
– volume: 11
  year: 2021
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib7
  article-title: Hypoxia-induced MALAT1 promotes the proliferation and migration of breast cancer cells by sponging MiR-3064-5p
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2021.658151
– volume: 72
  start-page: 7
  issue: 1
  year: 2022
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib2
  article-title: Cancer statistics, 2022
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21708
– volume: 10
  start-page: 370
  year: 2010
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib29
  article-title: Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-10-370
– volume: 625
  start-page: 220
  issue: 1–3
  year: 2009
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib30
  article-title: Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2009.06.063
– volume: 3
  issue: 1
  year: 2016
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib27
  article-title: Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature
  publication-title: Mol. Cell Oncol.
– volume: 10
  start-page: 1138
  year: 2020
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib41
  article-title: Chloroquine triggers cell death and inhibits PARPs in cell models of aggressive hepatoblastoma
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.01138
– volume: 324
  start-page: 1029
  issue: 5930
  year: 2009
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib17
  article-title: Understanding the Warburg effect: the metabolic requirements of cell proliferation
  publication-title: Science
  doi: 10.1126/science.1160809
– volume: 17
  start-page: 129
  issue: 2
  year: 2017
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib32
  article-title: Sorafenib and 2-deoxyglucose synergistically inhibit proliferation of both sorafenib-sensitive and -resistant HCC cells by inhibiting ATP production
  publication-title: Gene Expr.
  doi: 10.3727/105221616X693855
– volume: 43
  start-page: 981
  issue: 7
  year: 2011
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib19
  article-title: Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2010.08.009
– volume: 147
  start-page: 539
  issue: 3
  year: 2014
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib47
  article-title: Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-014-3128-y
– volume: 11
  start-page: 37
  issue: 1
  year: 2007
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib46
  article-title: A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.10.020
– volume: 14
  start-page: 3218
  issue: 9
  year: 2006
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib20
  article-title: Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2005.12.035
– volume: 293
  start-page: 167
  issue: 2
  year: 2010
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib28
  article-title: The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2010.01.006
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib1
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21660
– volume: 16
  start-page: 7888
  issue: 17
  year: 2008
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib31
  article-title: The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2008.07.076
– volume: 7
  start-page: 4
  year: 2019
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib14
  article-title: Hypoxia-modified cancer cell metabolism
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2019.00004
– volume: 17
  year: 2023
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib3
  article-title: Changing colorectal cancer trends in asians: epidemiology and risk factors
  publication-title: Oncol. Rev.
  doi: 10.3389/or.2023.10576
– volume: 24
  start-page: 2875
  issue: 7
  year: 2004
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib8
  article-title: Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.24.7.2875-2889.2004
– volume: 9
  issue: 1
  year: 2019
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib40
  article-title: Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
  publication-title: Sci. Rep.
– volume: 8
  start-page: 2844
  issue: 17
  year: 2009
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib44
  article-title: HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.17.9544
– volume: 49
  start-page: 6449
  issue: 23
  year: 1989
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib6
  article-title: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review
  publication-title: Cancer Res.
– volume: 3
  start-page: 83
  year: 2015
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib13
  article-title: The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
  publication-title: Hypoxia
  doi: 10.2147/HP.S93413
– volume: 79
  issue: 2
  year: 1983
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib33
  article-title: Comparison of simple potential functions for simulating liquid water
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.445869
– volume: 7
  issue: 1
  year: 2017
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib36
  article-title: CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-12513-1
– volume: 26
  start-page: 190
  issue: 2
  year: 2014
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib26
  article-title: Tumor vessel normalization by chloroquine independent of autophagy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.06.025
– volume: 5
  issue: 1
  year: 2015
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib42
  article-title: LON is the master protease that protects against protein aggregation in human mitochondria through direct degradation of misfolded proteins
  publication-title: Sci. Rep.
  doi: 10.1038/srep17397
– volume: 7
  start-page: 1395
  issue: 2
  year: 2016
  ident: 10.1016/j.freeradbiomed.2024.12.026_bib43
  article-title: Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6366
SSID ssj0004538
Score 2.4758198
Snippet Chloroquine (CQ), an autophagy antagonist, has been recently explored as a repurposable medicine for cancer; however the exact mechanism of its action is still...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 656
SubjectTerms And apoptosis
Apoptosis - drug effects
Autophagy - drug effects
Cell Hypoxia
Cell Proliferation - drug effects
Cell Survival - drug effects
Chloroquine - pharmacology
Colorectal cancer
Colorectal Neoplasms - drug therapy
Colorectal Neoplasms - genetics
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - pathology
CQ-Binding
CQ-Repositioning
Glycolysis
Glycolysis - drug effects
HCT116 Cells
Humans
Hypoxia
Membrane Potential, Mitochondrial - drug effects
Mitochondria - drug effects
Mitochondria - metabolism
MMP
PDK1
Protein Serine-Threonine Kinases - antagonists & inhibitors
Protein Serine-Threonine Kinases - chemistry
Protein Serine-Threonine Kinases - genetics
Protein Serine-Threonine Kinases - metabolism
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
Reactive Oxygen Species - metabolism
ROS
Title Chloroquine sensitises hypoxic colorectal cancer cells to ROS-mediated cell death via structural disruption of pyruvate dehydrogenase kinase 1
URI https://dx.doi.org/10.1016/j.freeradbiomed.2024.12.026
https://www.ncbi.nlm.nih.gov/pubmed/39657842
https://www.proquest.com/docview/3146621965
Volume 227
WOSCitedRecordID wos001410191800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1873-4596
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004538
  issn: 0891-5849
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6DRAvCDYG5WMyAvESZWrSxHFekMq0aUMwENukvkVuYisZa1KlH2r_BP-K_8W9dtK0RZOGEC9p67SxlXN6fexcHxPybsB4GHR4bHPGOzBAYcIWLnxE7zI4EYtwoHct-Rycn_N-P_zWav2q18LMboI85_N5OPqvUEMZgI1LZ_8C7uVFoQDeA-hwBNjheCfgj1IYgkO4R_k4xvR03G55bKWLUTHPYgtdqjHKoS8IIl5aOHevfR6-f72w9UoSVKFYaiUoEK1ZJizjM6s9OpJsXE5HtdIcLcrpDH4B300XSVlAu6BjtH5k-sVZFb8npZRWKcyTodr9Cam3-YD_S6Z5dFYqiD69dCiSjTOn2Q1Sa-2MTEuhH0VdDcUy4_hjKkw-SpEmFka29XkO169To-vJt3oBzlp-aIeHjg0aKlwN6K5xG6hCMvPZSu_OzB4vf3QcZg7j-lDBncAkBu19cAjt8PRssbth160FwAXWjpWDKnJAC3hbZMcN_BCC607v7Lj_acW2Xm-pvmztA_K2STS8tcrbpNJtQyEtiS4fk0fVWIb2DAefkJbMd8leLxeTYrig76nOLtYo75L7ZtPTxR75uUJQ2hCUVgSlDUGpISjVBKWTgq4SVJdSTVAKBKUNQWlDUFooWhOUrhGUGoJS5ym5Ojm-PDq1q11B7Ljr-hNb4ZAgECC9YpWwjuJBEgaOiLk_8JlKpFQe46rr8YR7yvU9RzqO4NKTMDQSKhbdfbKdF7l8TigH8S4YqFilPEx3FnqKRCYsdGJX8rBNvBqAaGTMX6I6K_I6WsMtQtwix40Atzb5UIMVVTrW6NMI2Ha3C7ypIY4g2uP9FLkspuOoC8KGuegC2ibPDPbLlnWhNOCe--Jfq39JHjZ_wFdkG_CTr8m9eAZ0KA_IVtDnBxXDfwOyGeaB
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chloroquine+sensitises+hypoxic+colorectal+cancer+cells+to+ROS-mediated+cell+death+via+structural+disruption+of+pyruvate+dehydrogenase+kinase+1&rft.jtitle=Free+radical+biology+%26+medicine&rft.au=Mir%2C+Irfan+Ahmad&rft.au=Mir%2C+Hilal+Ahmad&rft.au=Mehraj%2C+Umar&rft.au=Bhat%2C+Mohd+Younus&rft.date=2025-02-01&rft.pub=Elsevier+Inc&rft.issn=0891-5849&rft.volume=227&rft.spage=656&rft.epage=666&rft_id=info:doi/10.1016%2Fj.freeradbiomed.2024.12.026&rft.externalDocID=S0891584924011304
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0891-5849&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0891-5849&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0891-5849&client=summon